We are a global consumer health company, delivering over-the-counter products that empower individuals to take control of their health and well-being.
Millions worldwide are unable to fully meet their nutritional needs, leading to fatigue, weakened immunity, cognitive impairments, and long-term health risks. Many individuals remain unaware of their deficiencies or those they have a predisposed risk to.
DNA Testing offers consumers insights into genes they have that are associated with deficiencies in key micronutrients, due to the presence of Single Nucleotide Polymorphisms (SNPs) impacting absorption, metabolism or storage. Based on individual genetic risk, the consumer can then receive personalised nutritional or supplementation recommendations.
Typically, these tests consist of the following steps:
DNA Collection Kit purchased online or in-store
Consumer collects cheek swab or salvia sample at home
The sample is sent to a centralised lab for analysis
Results are shared to consumers digitally, typically via an app 2-3 weeks after the sample is received by the lab
The report provides the consumer insights into their individual risk of having a specific micronutrient deficiency
The typical commercial cost of these services for consumers is over $135.
The most established methodology used for this genetic analysis is microarray screening. We are interested in emerging technologies that can be used to offer a lower cost-per-test for consumers that maintain or exceed current accuracy.
We are looking for a low-cost genotyping technology—either lab-based or in-home—that accurately identifies SNPs associated with key micronutrient deficiencies, is compatible with non-invasive sample collection, and can be scaled for high-volume consumer testing.
The Q&A is now closed.